Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals and Orna Therapeutics announce a $4 billion collaboration to develop in vivo gene editing therapies ...

Finbold has selected three interesting pharmaceutical stocks that could see significant moves to the upside in 2025.

Vertex Pharmaceuticals (VRTX) is facing technical challenges, with its stock forming a Death Cross and down 15% in 6 months.

Vertex Pharmaceuticals Inc. closed $111.56 below its 52-week high ($519.88), which the company achieved on November 8th.

Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

The cloud solutions market is booming owing to technological advancements, rising investments, and increasing demand. Thus, ...

US stocks sold off sharply on Tuesday as bond yields hit a nine-month high on the back of stronger-than-expected economic ...

With Nvidia and Continental onboard, Aurora is gearing up to transform autonomous trucking at an unprecedented scale.

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...

Inovio Pharmaceuticals Inc. 18.13% $69.67M ...

The Roman Empire lowered IQ levels across Europe according to a new study, due to the vast quantities of lead pollution churned out by the booming metals industry. Researchers have said the massive ...